- 期刊
Clinical Treatment and Research Progress of Bone Marrow Mesenchymal Stem Cells
摘要
Bone marrow mesenchymal stem cells (MSC) have a high degree of self-renewal and multi-directional differentiation ability, and can be cultured, proliferated and passaged in vitro, and have tumor-tropism and low immunogenicity. At present, researchers at home and abroad have been exploring BMSC more and more deeply. BMSC has become a new hot spot and new direction in basic research and clinical treatment. This article reviews the biological characteristics, isolation and identification methods, clinical treatment, and basic research progress of BMSC.
參考文獻
I. Ullah, R. B. Subbarao, G. J. Rho. Human mesenchymal stem cells - current trends and future prospective. Biosci Rep, 2015, 35(2).
J. Wu, W. Zhang, Q. Ranet al. The Differentiation Balance of Bone Marrow Mesenchymal Stem Cells Is Crucial to Hematopoiesis. Stem Cells Int,2018,2018:1540148.
L. Lin, H. Lin, S. Baiet al. Bone marrow mesenchymal stem cells (BMSCs) improved functional recovery of spinal cord injury partly by promoting axonal regeneration. Neurochem Int, 2018, 115: 80-84.
R. G. Bagley, W. Weber, C. Rouleauet al. Human mesenchymal stem cells from bone marrow express tumor endothelial and stromal markers. Int J Oncol,2009,34(3):619-627.
D. Noel, D. Caton, S. Rocheet al. Cell specific differences between human adipose-derived and mesenchymal-stromal cells despite similar differentiation potentials. Exp Cell Res, 2008, 314 (7): 1575-1584.